Time-concentration profile of serum etanercept in Japanese patients with rheumatoid arthritis after treatment discontinuation before orthopedic surgery.
Nishida
Keiichiro
K
Department of Human Morphology, Science of Functional Recovery and Reconstruction, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama, Okayama, 700-8558, Japan. knishida@md.okayama-u.ac.jp
Hashizume
Kenzo
K
Kadota
Yasutaka
Y
Natsumeda
Masamitsu
M
Nakahara
Ryuichi
R
Saito
Taichi
T
Kanazawa
Tomoko
T
Ezawa
Kazuhiko
K
Ozaki
Toshihumi
T
D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000097:blood / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care; D057234:Preoperative Period; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood; D013997:Time Factors; D028761:Withholding Treatment
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept